Samuel Wadsworth
Technik-/Wissenschafts-/F&E-Leiter bei ULTRAGENYX PHARMACEUTICAL INC.
Vermögen: 54 206 $ am 31.05.2024
Aktive Positionen von Samuel Wadsworth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2017 | - |
| PRECISION BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 06.11.2021 | - |
| Independent Dir/Board Member | 06.11.2021 | - |
Karriereverlauf von Samuel Wadsworth
Ehemalige bekannte Positionen von Samuel Wadsworth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DIMENSION THERAPEUTICS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2013 | 01.11.2017 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.1993 | 01.01.2013 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - | - |
Ausbildung von Samuel Wadsworth
| The University of Chicago | Doctorate Degree |
| Southern Illinois University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| PRECISION BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
- Börse
- Insiders
- Samuel Wadsworth
- Erfahrung
